维普期刊资源整合服务平台（V6.5）

74篇 您的检索式：作者名="BOSI E"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	ICA12(SOX13) autoantibodies are unlikely to be a useful marker for pre-clinical type I diabetes显示文摘	Lampasona V Scirpoli M Bosi E	2001	Diabetologia2001，44，2：	1
2	Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin显示文摘	Bosi E Camisasca R P Collober C	2007	Diabetes Care2007，80，89：	1
3	Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes:a 24-week,double-blind,randomized trial显示文摘	Schweizer A Dejager S Bosi E	2009	Diabetes Obes Metab2009，11，8：	1
4	Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with mefformin 显示文摘	Bosi E Camisasca RP Collober C	2007	Diabetes Care2007，30，4：	1
5	Intravenous immunoglobulin enhances the clearance of fibrillar amyloid - beta peptide显示文摘	Istrin G Bosis E Solomon B	2006	J Neurosci Res2006，84，2：	1
6	IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with Type 2 diabetes (UKPDS 71)显示文摘	Bosi E Cull C A	2005	Diabetologia2005，48，6：	1
7	Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin显示文摘	Ahren B Foley JE Bosi E	2011	Diabetes Obes metab2011，13，：	1
8	Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide显示文摘	Istrin G Bosis E Solomon B	2006	J Neruosci Res2006，84，2：	1
9	Comparison of vildagliptin andmetformin monotherapy in elderly patients with type 2 diabetes:a24-week,double-blind,randomized trial显示文摘	Schweizer A Dejager S Bosi E	2009	Diabetes Obes Metab2009，11，8：	1
10	Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-native patients with type 2 diabetes mellitus显示文摘	Bosi E Dotta F Jia Y	2009	DiabetesObes Metab2009，11，：	1
11	Acute tonsillopharyngitis associated with atypical bacterial infection in children:natural history and impact of macrolide therapy显示文摘	Esposito S Bosis S Begliatti E		0，，02：	1
12	Autoantibody response to islet transplantation in type 1 diabetes显示文摘	Bosi E Braghi S Maffi P Scirpoli M Bertuzzi F Pozza G		0，，：	1
13	Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes显示文摘	Braghi S Bonifacio E Secchi A Di Carlo V Pozza G Bosi E		0，，：	1
14	Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus显示文摘	Bosi E Dotta F Jia Y	2009	Diabetes Obes Metab2009，11，5：	1
15	Time for testing incretin therapies in early type 1 diabetes? 显示文摘	Bosi E	2010	J Clin Endocrinol Metab2010，95，：	1
16	Increased intestinal permeability precedes clinical onset of type 1 diabetes显示文摘	Bosi E Molteni L Radaelli MG		0，，：	1
17	Effects of vildag- liptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin 显示文摘	Bosi E Camisasca RP Collober C	2007	Diabetes Care2007，30，4：	1
18	Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin显示文摘	Bosi E Camisasca RP Collober C	2007	Diabetes Care2007，30，4：	1
19	Effects of Vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin 显示文摘	BOSI E CAMISASCA R P COLLOBER C	2007	Diabetes Care2007，30，4：	1
20	Aspartic proteinases in normal lung and interstitial pulmonary diseases 显示文摘	Bosi F Silini E Luisetti M	1993	Am J Respir Cell Mol Biol1993，8，6：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示